Investor Roundtable - Health
This Investor Roundtable is an opportunity for the Conduit Connect investor community to take a deep dive into our portfolio companies currently tackling some of the biggest challenges surrounding health.
Founders will deliver presentations on their companies and afterwards we will have time for in-depth question and answers.
Companies presenting:
iFast's pioneering system reduces the time it takes to identify whether bacteria are resistant to antibiotics from 48 to 3-4 hours
Adora is developing a digital companion for women experiencing menopause symptoms using proprietary conversational-AI
Calla Lily's vaginal drug delivery solution supports the safe and effective delivery of drugs for fertility, pregnancy, and other gynaecological conditions
By registering for this event you are indicating that you are a HNW, sophisticated or professional investor as defined by the FCA.
This event is exempt from the general restriction in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds it is made exclusively to ‘investment professionals’ within the meaning of Article 19 of the Financial Services and Markets Act (Financial Promotion) Order 2005 (FinProm); persons believed on reasonable grounds to be ‘certified high net worth individuals’ within the meaning of Article 48 FinProm; persons who are ‘certified sophisticated investors’ within the meaning of Article 50 FinProm; and persons who are ‘self-certified sophisticated investors’ within the meaning of Article 50A FinProm.
If you are in any doubt about the investment to which this email relates, you are strongly recommended to consult an appropriately authorised financial adviser qualified to give advice in relation to investment in companies presented during the roundtable. An investment in the companies presented during the roundtable will not necessarily be suitable for all recipients of this email. Applications to subscribe for shares will only be accepted at the companies presented during the roundtable's discretion from persons eligible to invest.